First Bancshares, Inc. Reports Net Income of $1.17 Million

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
246
First Bancshares, Inc. Reports Net Income of $1.17 Million or $0.75 Per Diluted Share for the Year Ended December 31, 2016

MOUNTAIN GROVE, Mo., Feb. 24, 2017 (GLOBE NEWSWIRE) -- First Bancshares, Inc. (“Company”), (OTCQB:FBSI), the holding company for First Home Bank (“Bank”), today announced its financial results for the quarter and year ended December 31, 2016.

For the quarter ended December 31, 2016, the Company had net income of $677,000, or $0.43 per share – diluted, compared to net income of $378,000, or $0.24 per share – diluted for the quarter ended December 31, 2015.  The $299,000 increase in net income for the quarter ended December 31, 2016 compared to the quarter ended December 31, 2015 is attributable to an increase of $83,000 in net interest income, an increase of $140,000 in non-interest income and a $609,000 increase in income tax benefit.  This was partially offset by a $35,000 increase in provision for loan losses, a $120,000 decrease in gain on sale of investments and a $378,000 increase in non-interest expenses.

“We are pleased with our continued progress.  The results we achieved for the fourth quarter reflect the successful execution of our strategy to increase loan volumes while maintaining a very high standard for asset quality through consistent prudent underwriting standards,” said R. Bradley Weaver, Chairman, President and Chief Executive Officer of the Company. “We are very proud of the improvements we have made and are continuing to make.  The improvements are a result of the commitment of our employees to our principles of sound banking practices and they position us to deliver profitable growth and long-term value to our shareholders,” Weaver concluded.

During the quarter ended December 31, 2016, net interest income increased by $83,000, or 5.90%, to $1.49 million from $1.41 million during the same quarter in 2015.  This increase in net interest income was the result of an increase in interest income of $103,000, or 6.08% and was partially offset by an increase of $20,000, or 6.97%, in interest expense.  The increase in interest income is due to the growth in the Company’s loan portfolio. At December 31, 2016, the Company’s loan origination commitments were approximately $20.7 million compared to $14.3 million at December 31, 2015. Loan applications that are accepted for processing through origination and funding are included in the Company’s loan origination pipeline.  The increase in interest expense was primarily the result of an increase in the Company’s deposit portfolio.

There was no provision for loan losses for the quarter ended December 31, 2016.  The Company recaptured $35,000 in provision for loan losses for the quarter ended December 31, 2015.  The $35,000 recapture represented specific recoveries from three loans that were previously charged off.  Classified loans at December 31, 2016 were $895,000 compared to $1.31 million at December 31, 2015.  The allowance for loan losses at December 31, 2016 was $1.71 million, or 1.23% of total loans, compared to $1.70 million, or 1.32% of total loans at December 31, 2015.

For the quarter ended December 31, 2016, the Company did not sell any investments.  For the quarter ended December 31, 2015, the Company had a gain on sale of investments of $120,000.  The gain recognized in 2015 is attributable to a gain recognized on the sale of a single investment security.

Non-interest income increased by $140,000, or 107.69% to $270,000 for the quarter ended December 31, 2016 from $130,000 for the same quarter in 2015.  The increase was the result of a decrease in loss on sale of fixed assets of $131,000.  The loss incurred in 2015 represented a loss on the sale of a building lot that was no longer needed as a future building site for a bank location.  This was partially offset by an increase of $1,000 in other non-interest income items.

Non-interest expense increased by $378,000, or 26.81%, to $1.79 million for the quarter ended December 31, 2016 from $1.41 million for the quarter ended December 31, 2015.  The increase in non-interest expense reflects an increase of $360,000 in salaries and employee benefits, which were paid to employees in recognition of their contribution and commitment to improving the performance and profitability of the Company and the Bank.  The increase in non-interest expense also was attributable to an increase of $49,000 in professional fees consisting of legal, accounting and consulting service related expenses.  These increases were partially offset by a decrease of $18,000 in premises and fixed assets and a $13,000 decrease in other non-interest expense items.

For the quarter ended December 31, 2016, the Company recognized an income tax benefit of $705,000 compared to an income tax benefit of $96,000 for the quarter ended December 31, 2015.  The income tax benefit recorded for the quarter ended December 31, 2016 is the result of the Company recapturing remaining federal net operating loss carryforwards that had previously been fully reserved.  The income tax benefit recorded for the quarter ended December 31, 2015 is the result of the Company recapturing Missouri Income Tax Credits that had previously been fully reserved.

For the year ended December 31, 2016, the Company had net income of $1.17 million, or $0.75 per share – diluted, compared to net income of $3.10 million, or $2.00 per share – diluted for the year ended December 31, 2015.  The $1.93 million decrease in net income for the year ended December 31, 2016 compared to the year ended December 31, 2015 is attributable to a decrease of $95,000 in gain on sale of investments, an increase of $507,000 in non-interest expense and a decrease of $1.94 million in income tax benefit.  This was partially offset by an increase of $405,000 in net interest income, a $25,000 decrease in provision for loan losses and a $183,000 increase in non-interest income.

During the year ended December 31, 2016, net interest income increased by $405,000, or 7.25%, to $6.00 million from $5.59 million for the year ended December 31, 2015.  The increase in net interest income was the result of an increase in interest income of $511,000, or 7.63% and was partially offset by an increase of $106,000, or 9.55% in interest expense. 

There was no provision for loan losses for the year ended December 31, 2016 compared to a $25,000 provision expense during the same period in 2015.  The decrease in the provision for loan losses during the year ended December 31, 2016 is attributable to our commitment to high quality assets in our loan portfolio.

During the year ended December 31, 2016, the Company had a gain on sale of investments of $14,000 compared to a gain on sale of investments of $109,000 during the same period in 2015.

Non-interest income increased by $183,000, or 22.32%, to $1.00 million for the year ended December 31, 2016, compared to $820,000 for the same period in 2015.  The increase in non-interest income reflects a decrease of $131,000 in loss on sale of fixed assets, a $29,000 increase in service charges on deposit accounts and a $23,000 increase in other non-interest income.

Non-interest expense increased by $507,000, or 8.76%, to $6.30 million for the year ended December 31, 2016, compared to $5.79 million for the year ended December 31, 2015.  The increase is attributable to an increase in salaries and employee benefits of $488,000, which were paid to employees in recognition of their contribution and commitment to improving the performance and profitability of the Company and the Bank.  The increase in non-interest expense also was attributable to an increase of $35,000 in professional fees consisting of legal, accounting and consulting service related expenses.  This was partially offset by a decrease of $16,000 in other non-interest expense.

During the year ended December 31, 2016, two of the Bank’s branch offices located in Marshfield, Missouri, were consolidated into one branch office.  The consolidation is expected to reduce occupancy and equipment expenses in future periods.

Total consolidated assets at December 31, 2016 were $219.48 million, compared to $213.03 million at December 31, 2015, representing an increase of $6.45 million, or 3.03%.  Stockholders’ equity at December 31, 2016 was $19.77 million, or 9.01% of assets, compared with $18.55 million, or 8.71% of assets at December 31, 2015.  Book value per common share increased to $12.76 at December 31, 2016 from $11.98 at December 31, 2015.  The $1.22 million, or 6.56% increase in stockholders’ equity was attributable to an increase in the unrealized gains on available-for-sale securities, net of income taxes of $50,000 and by net income of $1.17 million for the year ended December 31, 2016.

Net loans receivable increased $12.28 million, or 9.86%, to $136.80 million at December 31, 2016 from $124.53 million at December 31, 2015.  Loan growth continues to be the primary focus to improve earnings.  This focus is tempered with the Company’s continuous attention to high quality underwriting and strong asset quality management.  Our strategy is to increase the size of the loan portfolio without any sacrifice to quality.  Nonperforming loans at December 31, 2016 were $246,000, or 0.18% of net loans, compared to $697,000 in nonperforming loans, or 0.56% of net loans at December 31, 2015.  Deposits increased $5.01 million, or 2.84% to $181.73 million at December 31, 2016 from $176.71 million at December 31, 2015.  FHLB advances decreased $1.0 million or 7.69%, to $12.00 million at December 31, 2016 from $13.0 million at December 31, 2015.

First Bancshares, Inc. is the holding company for First Home Bank, a FDIC-insured commercial bank chartered by the State of Missouri that conducts business from its home office in Mountain Grove, Missouri, and seven full service offices in Marshfield, Ava, Gainesville, Sparta, Springfield, Crane, and Kissee Mills, Missouri.

The Company and its wholly-owned subsidiary, First Home Bank, may from time to time make written or oral “forward-looking statements” in its reports to shareholders, and in other communications by the Company, which are made in good faith by the Company pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements include statements with respect to the Company’s beliefs, expectations, estimates and intentions that are subject to significant risks and uncertainties, and are subject to change based on various factors, some of which are beyond the Company’s control. Such statements address the following subjects: future operating results; customer growth and retention; loan and other product demand; earnings growth and expectations; new products and services; credit quality and adequacy of reserves; results of examinations by our bank regulators, technology, and our employees. The following factors, among others, could cause the Company’s financial performance to differ materially from the expectations, estimates and intentions expressed in such forward-looking statements: the strength of the United States economy in general and the strength of the local economies in which the Company conducts operations; the effects of, and changes in, trade, monetary, and fiscal policies and laws, including interest rate policies of the Federal Reserve Board; inflation, interest rate, market, and monetary fluctuations; the timely development and acceptance of new products and services of the Company and the perceived overall value of these products and services by users; the impact of changes in financial services’ laws and regulations; technological changes; acquisitions; changes in consumer spending and savings habits; and the success of the Company at managing and collecting assets of borrowers in default and managing the risks of the foregoing. 

The foregoing list of factors is not exclusive. The Company does not undertake, and expressly disclaims any intent or obligation, to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

First Bancshares, Inc. and Subsidiaries
Financial Highlights
(In thousands, except per share amounts)
          
          
   Quarter Ended Year Ended
   December 31, December 31,
    2016   2015   2016   2015 
Operating Data:        
          
Total interest income $1,797  $1,694  $7,209  $6,698 
Total interest expense  307   287   1,216   1,110 
 Net interest income  1,490   1,407   5,993   5,588 
Provision for loan losses  -   (35)  -   25 
 Net interest income after provision for loan losses  1,490   1,442   5,993   5,563 
Gain (loss) on sale of investments  -   120   14   109 
Non-interest income  270   130   1,003   820 
Non-interest expense  1,788   1,410   6,296   5,789 
Income before taxes  (28)  282   714   703 
Income tax expense (benefit)  (705)  (96)  (454)  (2,399)
 Net income $677  $378  $1,168  $3,102 
          
 Earnings per share $0.43  $0.24  $0.75  $2.00 
          
   At At    
   December 31, December 31,    
Financial Condition Data:  2016   2015     
          
Cash and cash equivalents $4,708  $9,573     
 (excludes CDs)      
Investment securities  62,531   64,835     
 (includes CDs)      
Loans receivable, net  136,802   124,527     
Total assets  219,482   213,030     
Deposits  181,727   176,713     
Repurchase agreements  5,185   4,127     
FHLB advances  12,000   13,000     
Stockholders' equity  19,767   18,550     
Book value per share $12.76  $11.98     
          

Contact:  R. Bradley Weaver, Chairman, President and CEO - (417) 926-5151

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading